CGC

Canopy Growth Corp

Marijuana Industry

As Pot Stocks Reach Record Highs, Here's What's Coming Next

For pot stock investors, the first half of 2018 stank.

It was choppy – to say the least – thanks in no small part to meddling from U.S. Attorney General Jeff Sessions.

But I kept telling you to keep the faith – that a number of catalysts were lining up that would once again send legal marijuana stocks into the stratosphere.

I was right – and those of you who listened can feel a bit smug.

While other investors are scrambling to get back into legal cannabis, you're watching your holdings grow… and grow.

We can date cannabis' latest surge to Aug. 15. That was the day Constellation Brands Inc., the beverage giant behind Corona beer and Robert Mondavi wines, announced its plan to spend $3.8 billion to increase its stake in Canopy Growth Corp. to 38%.

In other words, a mainstream corporation had weighed the risks – and marched forward with a plan to dive into the marijuana industry… to the tune of billions of dollars.

The news sent marijuana stocks soaring.

This one stat shows it all: The bellwether North American Marijuana Index has climbed more than 175% since lows reached on Sept. 7, 2017.

And this is just the start…

In today's report, I'll tell you why that's so.

Plus, I'll reveal the latest Big Alcohol company to come sniffing around the cannabis industry.

And I'll help you find four pot stocks with triple-digit potential to buy now.

Before the next catalyst hits.

Take a look...

stocks

These Marijuana Stocks Could Soar When Big Alcohol Invests in Cannabis

There's a revolution underway in the legal cannabis industry. And it's about to storm the gates of corporate America.

Some of the nation's largest beverage companies, like Constellation Brands Inc., are pouring millions of dollars into legal cannabis.

In fact, Constellation just announced it plans to spend $3.8 billion on a stake in Canopy Growth Corp, a leading cannabis company.

IPOs

The U.S. Cannabis IPO Wave Will Be a Massive Payday

Canada's fully legal "adult use" marijuana market throws the wild success of Canadian cannabis stocks into sharp relief…

In just the past year, Canopy Growth is up over 416%.

Cronos Group is up over 301% in that same time.

And Tilray, which only went public in mid-July, is up 577%.

These gains raise an important question: How can you make money on U.S.-based cannabis companies during this historic growth cycle?

After all, at about $8.5 billion, the United States cannabis industry is already larger than the Canadian market is projected to grow by 2022. And that growth isn't going to slow down anytime soon – Arcview Market Research and BDS Analytics project that cannabis spending in the United States will reach $23.4 billion by 2022, a 275% increase in just five years.

That's an extremely conservative estimate, by the way, in that it assumes few, if any, additional states will legalize cannabis for recreational use. But because other states are coming on board and will likely continue to do so, other estimates have the market growing to $50 billion by 2022 – a 42.5% annual growth rate.

Yet there are no fewer than seven Canadian cannabis companies with a market value in excess of $1 billion, compared with only one U.S.-based outfit.

I'm looking for that to change – in a big way.

This will give you an idea of the size of the potential opportunity on our hands...